Category: spain

PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

Question: Do you value Retraction Watch? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support us?

When researchers submitted a paper about a type of microparticle to PNAS, they wanted to give credit where it was due, and cite an unpublished manuscript that helped guide their work. But the journal’s policy forbid citing unpublished work, and the reference was removed before publication. Now, concerns from the authors of that unpublished work have prompted the journal to have a change of heart.  

Continue reading PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

Child took wrong compound for over a year after “communication error”

Credit: Steven Depolo, Flickr

A journal is retracting a paper after it discovered researchers gave a child the wrong supplement for more than a year.

Rhiannon Bugno, managing editor for Biological Psychiatry, told Retraction Watch the mix-up did not put the patient at risk. However, the mistake was enough for the journal’s editor, John Krystal, of Yale University, to request the retraction of a 2016 paper describing the young girl’s experience taking the compound,“Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.”

Originally published June 17, 2016, the paper was retracted Jan. 15. Led by corresponding author Xavier Altafaj, of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL), researchers described using an amino acid, D-serine, to treat a child with a rare genetic disorder that affects neurons.

According to the notice, the researchers did use D-serine in lab work used as proof-of-concept; however, when it came time to try it in the patient, as a result of a “communication error:”

Continue reading Child took wrong compound for over a year after “communication error”

Lead author changes co-author’s name on a paper without his permission. Why?

Here’s a rather odd case: A postdoctoral researcher says his former boss changed his name on a paper without his permission. According to the postdoc, Antonio Herrera-Merchan, his principal investigator at University of Granada insisted on the name change to distance them both from a scandal in Herrera-Merchan’s previous lab.

After publishing a paper in Oncotarget in October 2017, Herrera-Merchan’s name was changed on the paper. Now, two versions of the paper exist: an earlier version that lists Antonio Herrera-Merchan as first author, and the current version that spells his name without “Merchan.”*  

We’ve obtained an email exchange between his former boss, Pedro Medina, and Oncotarget, requesting the name change.

Medina told us Herrera-Merchan always used the name “Herrera” in his lab: Continue reading Lead author changes co-author’s name on a paper without his permission. Why?

Author wins judgment against Elsevier in lawsuit over retraction

The author of a 2009 commentary exploring “sexually specific infanticide” in bears has won a judgment against Elsevier for using “untruthful and unverified” language in a 2011 retraction notice.

The last author, Miguel Delibes, who filed the suit in 2014, explained that the judge ruled he should accept the journal’s decision to retract his paper, but “confirmed that my honorability had been damaged” by the false accusation in the original retraction notice. According to a new note on the paper from the publisher, the court required the journal to publish part of its ruling to correct the record. Continue reading Author wins judgment against Elsevier in lawsuit over retraction

Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Via Wikimedia

Title: Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis

What Caught Our Attention: A big peer review (and perhaps academic mentorship) fail.  These researchers used the wrong anticoagulant for their blood samples, leading them to believe that certain blood components were fighting microbes. The authors counted the number of colonies to show how well or poorly Tuberculin mycobacteria were growing in cultures — but blood samples need anticoagulants to prevent clots before analysis, and they used an anticoagulant that actually prevented the microbes from colonizing. The authors (and reviewers) should have known this from  Continue reading Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Stem cell scientist appealing dismissal loses another paper

Susana Gonzalez

A once-prominent stem cell biologist, who recently lost both her job and a sizable grant, has lost her fifth paper.

Recently, Molecular and Cellular Biology retracted a 2003 paper by Susana Gonzalez. Last February, the National Center for Cardiovascular Research (CNIC) in Spain dismissed her from her position over allegations of misconduct. The reason: suspicions of data manipulation.

As with a previous retraction, the journal said Gonzalez “could not be reached for approval of this retraction.”  

Here’s the full notice:

Continue reading Stem cell scientist appealing dismissal loses another paper

Journal flags four papers by researcher in Spain over figure issues noted on PubPeer

A journal has issued expression of concerns (EOCs) for four papers after a concerned reader notified the editors of issues in several figures.

According to the EOCs, the Journal of Cell Science (JCS) discussed the concerns with the corresponding author, José Ignacio Rodriguez-Crespo, and subsequently notified his institution, Complutense University of Madrid. Last year, all four papers were questioned on PubPeer (1, 2, 3, 4).

The journal’s executive editor, Sharon Ahmad, told us: Continue reading Journal flags four papers by researcher in Spain over figure issues noted on PubPeer

Curious: A paper’s acknowledgments harshly criticized Spanish gov’t funding. Now two authors object.

In 2014, researchers condemned the Spanish Government for “destroying the R&D horizon of Spain and the future of a complete generation” in the acknowledgment section of a paper about wireless networks.

Three years later, the two last authors of the paper are protesting that protest, issuing a correction to alert readers that they did not approve the language. Here’s the text of the corrigendum notice, which mentions Juan M. Górriz and Javier Ramírez, both based at University of Granada: Continue reading Curious: A paper’s acknowledgments harshly criticized Spanish gov’t funding. Now two authors object.

Nature retracts paper by stem cell scientist appealing her dismissal

Susana Gonzalez

A once-rising star in stem cell biology — who recently lost both her job and a sizable grant — has had a fourth paper retracted.

The notice — issued by Nature for a 2006 letter — cites duplicated images, and a lack of raw data to verify the findings. First author Susana Gonzalez — who was dismissed from her position at the National Center for Cardiovascular Research (CNIC) in Spain last February over allegations of misconduct — couldn’t be reached by the journal.

Here’s the full text of the retraction notice:

Continue reading Nature retracts paper by stem cell scientist appealing her dismissal

Author of retracted gene editing paper alleges “bullying” by former PI

In the fall of 2015, out-of-work stem cell biologist Mavi Camarasa decided she had waited long enough. It had been three years since she and a colleague were, best they could tell, the first to successfully correct the most common cystic fibrosis mutation in stem cells derived from a patient.

But her former lab director, Daniel Bachiller, had blocked her from writing even a short report, she told Retraction Watch:

He said we are not submitting at this time, wait until [the project is] complete. “Wait, wait,” is the only answer I’d had from him ever.

Though she’d left the Spanish regenerative medicine lab in 2013 to take care of an ailing parent and had mostly been scooped by another group in April of that year, Camarasa thought she still might be able to get something out of the project. She hatched a plan to make him an offer he couldn’t refuse — an already accepted manuscript where all he would have to do is attach his name at the last minute.

But this story didn’t turn out exactly how she’d hoped — and illustrates how the pressure to publish can affect researchers at different levels in the lab.

Continue reading Author of retracted gene editing paper alleges “bullying” by former PI